Key data
Open—
From 52W high—
Volume—
Market cap—
P/E (TTM)—
P/S (TTM)—
Div yield—
Key data
Open
—
From 52W high
—
Volume
—
Market cap
—
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
—
P/E (TTM)
—
RSI (14)
—
MomentumView details →
1D Return
—
YTD Return
—
Latest newsMore news →
Sandoz announced a licensing, development, manufacturing and commercialisation agreement with mAbxience for a proposed emicizumab biosimilar, with Sandoz holding exclusive global commercialisation rights excluding Argentina, Uruguay and Paraguay.2d agoOn September 15, US-listed ADRs of Japanese companies traded with a slight selling bias, with Chugai Pharmaceutical and Takeda Pharmaceutical among the decliners, while Chicago Nikkei 225 futures settled at 63,405 yen, 285 yen above the Osaka daytime level.5d ago